Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Diseases

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 48 articles: HTML format Text format

Single Articles

January 2012
1. PERSSON EC , Graubard BI, Evans AA, London WT, et al
   Dichlorodiphenyltrichloroethane (DDT) and risk of hepatocellular carcinoma.
   Int J Cancer. 2012 Jan 30. doi: 10.1002/ijc.27459.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
2. GUO Z , Wu C, Wang X, Wang C, et al
   A polymorphism at the miR-502 binding site in the 3' untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome.
   Int J Cancer. 2011 Nov 18. doi: 10.1002/ijc.27352.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. DE FINE LICHT S , Schmidt LS, Rod NH, Schmiegelow K, et al
   Hepatoblastoma in the nordic countries.
   Int J Cancer. 2011 Nov 18. doi: 10.1002/ijc.27351.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. LI Q , Li WW, Yang X, Fan WB, et al
   Type 2 Diabetes and hepatocellular carcinoma: A Case-control study in patients with chronic hepatitis B.
   Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27337.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. WANG XQ , Zhang W, Lui EL, Zhu Y, et al
   Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma.
   Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27336.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
6. PRAKOBWONG S , Charoensuk L, Hiraku Y, Pinlaor P, et al
   Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
   Int J Cancer. 2011 Sep 20. doi: 10.1002/ijc.26443.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. ZHANG CH , Xu GL, Jia WD, Li JS, et al
   Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: A meta-analysis of randomized controlled trials.
   Int J Cancer. 2011;129:1254-64.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. NAGASHIO R , Arai E, Ojima H, Kosuge T, et al
   Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage.
   Int J Cancer. 2011;129:1170-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
9. SHIMIZU S , Takehara T, Hikita H, Kodama T, et al
   Inhibition of autophagy potentiates the anti-tumor effect of the multi-kinase inhibitor sorafenib in hepatocellular carcinoma.
   Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26374.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. BAN G , Jeong JS, Kim A, Kim SJ, et al
    Selective and efficient retardation of cancers expressing cytoskeleton-associated protein 2 by targeted RNA replacement.
    Int J Cancer. 2011;129:1018-29.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
11. TOIYAMA Y , Yasuda H, Saigusa S, Matushita K, et al
    Co-expression of hepatocyte growth factor (HGF) and c-Met predicts peritoneal dissemination established by autocrine HGF/c-Met signaling in gastric cancer.
    Int J Cancer. 2011 Jul 27. doi: 10.1002/ijc.26330.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. DITURI F , Mazzocca A, Lupo L, Edling CE, et al
    PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma.
    Int J Cancer. 2011 Jul 27. doi: 10.1002/ijc.26319.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. ZHANG CH , Xu GL, Jia WD, Ge YS, et al
    Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis.
    Int J Cancer. 2011 Jul 21. doi: 10.1002/ijc.26301.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
14. CHIBA T , Suzuki E, Negishi M, Saraya A, et al
    3-deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells.
    Int J Cancer. 2011 Jun 29. doi: 10.1002/ijc.26264.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. TAKEICHI T , Mocevicius P, Deduchovas O, Salnikova O, et al
    alpha(L) beta(2) integrin is indispensable for CD8+ T-cell recruitment in experimental pancreatic and hepatocellular cancer.
    Int J Cancer. 2011 Jun 6. doi: 10.1002/ijc.26223.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LEMMENS VE , Klaver YL, Verwaal VJ, Rutten HJ, et al
    Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
    Int J Cancer. 2011;128:2717-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
17. LIANG Y , Li WW, Yang BW, Tao ZH, et al
    Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26166.
    PubMed     Text format     Related articles   
    
    
    
    
18. WANG C , Wang X, Gong G, Ben Q, et al
    Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26165.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
19. NISCHALKE HD , Coenen M, Berger C, Aldenhoff K, et al
    The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Int J Cancer. 2011 Apr 15. doi: 10.1002/ijc.26143.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. AMMERPOHL O , Pratschke J, Schafmayer C, Haake A, et al
    Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma.
    Int J Cancer. 2011 Apr 15. doi: 10.1002/ijc.26136.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. CHAGAS CE , Bassoli BK, de Souza CA, Deminice R, et al
    Folic acid supplementation during early hepatocarcinogenesis: Cellular and molecular effects.
    Int J Cancer. 2011 Apr 8. doi: 10.1002/ijc.25886.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
22. MAASS T , Thieringer FR, Mann A, Longerich T, et al
    Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis.
    Int J Cancer. 2011;128:1259-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. LONGERICH T , Mueller MM, Breuhahn K, Schirmacher P, et al
    Oncogenetic tree modeling of human hepatocarcinogenesis.
    Int J Cancer. 2011 Mar 11. doi: 10.1002/ijc.26063.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. LI C , Wang S, Jiang W, Li H, et al
    Impact of intracellular alpha fetoprotein on RAR-mediated expression of GADD153 in human hepatoma cell lines.
    Int J Cancer. 2011 Mar 1. doi: 10.1002/ijc.26025.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
25. TSUNEMATSU H , Tatsumi T, Kohga K, Yamamoto M, et al
    Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26003.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. TOMIMARU Y , Eguchi H, Wada H, Kobayashi S, et al
    IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma.
    Int J Cancer. 2011 Feb 16. doi: 10.1002/ijc.25994.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
27. CILLO C , Schiavo G, Cantile M, Bihl MP, et al
    The HOX gene network in hepatocellular carcinoma.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25941.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. THAIPARAMBIL JT , Bender L, Ganesh T, Kline E, et al
    Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25938.
    PubMed     Text format     Related articles   
    
    
    
    
29. ZHAO YM , Wang L, Dai Z, Wang DD, et al
    Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ZHAO W , Zhang L, Yin Z, Su W, et al
    Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
31. WITKOWSKI M , Spangenberg HC, Neumann-Haefelin C, Buttner N, et al
    Lack of ex vivo peripheral and intrahepatic alpha-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. LU WJ , Lee NP, Kaul SC, Lan F, et al
    Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. WEI G , Wang M, Hyslop T, Wang Z, et al
    Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo.
    Int J Cancer. 2010;127:2949-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. TIAN L , Wang Y, Xu D, Gui J, et al
    Serological AFP/ golgi protein 73 could be a new diagnostic parameter of hepatic diseases.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. SUNAGOZAKA H , Honda M, Yamashita T, Nishino R, et al
    Identification of a secretory protein c19orf10 activated in hepatocellular carcinoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. ERTLE J , Dechene A, Sowa JP, Penndorf V, et al
    Nonalcoholic fatty liver disease progresses to HCC in the absence of apparent cirrhosis.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. TANAKA H , Kimura T, Kudoh S, Mitsuoka S, et al
    Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. LIU C , Gong K, Mao X, Li W, et al
    Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
39. ZHANG CH , Xu GL, Jia WD, Li JS, et al
    Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: A meta-analysis of randomized controlled trials.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
40. PENNA F , Bonetto A, Muscaritoli M, Costamagna D, et al
    Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?
    Int J Cancer. 2010;127:1706-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
41. ROTHMEIER AS , Schneiders UM, Wiedmann RM, Ischenko I, et al
    The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis.
    Int J Cancer. 2010;127:1096-105.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. GOASGUEN N , de Chaisemartin C, Brouquet A, Julie C, et al
    Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents.
    Int J Cancer. 2010;127:1028-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
43. FAN R , Li X, Du W, Zou X, et al
    Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. NAKAMURA K , Hongo A, Kodama J, Hiramatsu Y, et al
    The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
45. GANNON PO , Medelci S, Le Page C, Beaulieu M, et al
    Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. HUNG CH , Lee CM, Wang JH, Hu TH, et al
    Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. MARQUARDT JU , Quasdorff M, Varnholt H, Curth HM, et al
    Neighbor of punc E11, a novel onco-fetal marker for hepatocellular carcinoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
48. SHINAGAWA K , Kitadai Y, Tanaka M, Sumida T, et al
    Mesenchymal stem cells enhance growth and metastasis of colon cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: